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ABSTRACT
Traditional fermented buffalo milk in Indonesia (dadih) has been believed to have a beneficial impact on human health,
which could be related to the properties of the lactic acid bacteria (LAB) involved in its fermentation process. In previous
studies, it was discovered that strains of dadih lactic isolates possessed some beneficial properties in vitro. In the present study,
the adhesion capacity of specific LAB isolates from dadih to intestinal mucus was analyzed. Further, the ability to inhibit
model human pathogens and displace them from mucus was assessed. The adhesion of tested LAB strains was strain-dependent
and varied from 1.4 to 9.8%. The most adhesive Lactobacillus plantarum strain was IS-10506, with 9.8% adhesion. The
competition assay between dadih LAB isolates and pathogens showed that a 2-h preincubation with L. plantarum at 37C
significantly reduced pathogen adhesion to mucus. All tested LAB strains displaced and inhibited pathogen adhesion, but the
results were strain-specific and dependent on time and pathogen strains. In general, L. plantarum IS-10506 showed the best
ability against pathogen adhesion.
Specific selected lactic acid bacteria (LAB) strains
from the genera Lactobacillus and Bifidobacterium have
been increasingly introduced and characterized as probiot-
ics for functional food products. A probiotic has been de-
fined as a ‘‘live microorganism which when administered
in adequate amounts confers a health benefit on the host’’
(11). Many criteria have been suggested for the selection
of probiotics, including safety, tolerance to gastrointestinal
conditions, ability to adhere to the gastrointestinal mucosa,
and competitive exclusion of pathogens (7, 9, 22). Adhe-
sion to the intestinal mucosa would allow colonization, al-
though transient, of the human intestinal tract (2) and has
been related to the ability to modulate the immune system,
especially during its development (29). Thus, adhesion is
one of the main selection criteria for new probiotic strains
(13, 26). In spite of the lack of definitive evidence, a re-
lationship between in vitro adhesion and in vivo coloniza-
tion has been reported (6, 10). In addition, adhesion to and
colonization of the mucosal surfaces are possible protective
mechanisms against pathogens through competition for
binding sites and nutrients (34) or immune modulation (26).
Moreover, it has been shown that certain lactobacilli share
carbohydrate-binding specificities with some enteropatho-
gens (19), and inhibition of pathogen adhesion by steric
hindrance has been reported (15). This provides the ratio-
nale for the use of probiotics to prevent infection by inhib-
iting the adhesion of pathogens by competitive exclusion.
The LAB strains used in this study were isolated from
the Indonesian traditional fermented buffalo milk dadih.
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Dadih is fermented milk in bamboo tubes by natural LAB,
and the resulting product is thought to be beneficial to hu-
man health. The benefits may be a result of the presence
of the indigenous LAB involved in dadih fermentation. Our
interest in indigenous dadih LAB strains is based on their
tolerance to acid and bile, their antimicrobial activity
against pathogenic bacteria, and their antimutagenic prop-
erties (30, 31). The present study was designed to charac-
terize both the adhesive properties of the specific LAB
strains and their ability to inhibit the adhesion or displace-
ment of model pathogens. This study provides a basis for
the selection of natural probiotics with the ability to ex-
clude, displace, and inhibit intestinal pathogens in the hu-
man intestinal mucus system (21, 22).
MATERIALS AND METHODS
Bacterial strains and culture conditions. The indigenous
dadih LAB strains were Lactobacillus plantarum IS-10506 and
IS-20506 and Enterococcus faecium IS-27526, IS-23427, and IS-
16183. All strains were isolated from dadih fermented milk (30)
and were identified by 16S rRNA gene sequencing as L. plantar-
um (GenBank accession no. DQ860148 and DC860149) and E.
faecium (GenBank accession no. EF068251, EF068250, and
EF068249). All strains were kept in the University of Turku cul-
ture collection. The LAB isolates were cultured in deMan Rogosa
Sharpe (MRS) broth (Scharlau Microbiology, Barcelona, Spain)
for 48 h at 37C, harvested by centrifugation, and freeze-dried and
stored in the Functional Foods Forum Culture Collection, Uni-
versity of Turku, Finland. For assays with freshly grown bacteria,
the bacteria were cultured in MRS broth for 18 h at 37C under
aerobic conditions, harvested by centrifugation (3,200  g, 4C,
20 min), and washed twice with phosphate-buffered saline (PBS;
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pH 7.0) buffer. The viability of the cells was tested on MRS agar
plates.
The bacterial pathogens used in this study were Bacteroides
vulgatus DSM 1447, Clostridium histolyticum DSM 627, Esche-
richia coli K-2, Salmonella enterica serovar Typhimurium ATCC
12028, and Staphylococcus aureus DSM 20231. Bacterial patho-
gens were grown in Gifu anaerobic medium (Nissui Pharmaceu-
tical, Tokyo, Japan) under anaerobic conditions (10% H2, 10%
CO2, and 80% N2; Concept 400 anaerobic chamber, Ruskinn
Technology, Leeds, UK).
Bacteria were metabolically labeled by the addition of titrated
thymidine at 10 l/ml ([5-3H]thymidine, 120 Ci/mmol; Amer-
sham Biosciences, Buckinghamshire, UK). All bacterial cultures
were incubated at 37C.
Mucus adhesion assay. Human intestinal mucus was isolat-
ed from the healthy part of resected colonic tissue as described
earlier (20, 22). Before use, the protein concentration was deter-
mined by a modification of the method of Lowry et al. (17) as
described by Miller and Hoskins (18), with bovine serum albumin
(Sigma, St. Louis, Mo.) as the standard. Human mucus was dis-
solved (0.5 mg of protein per ml) in HEPES (N-2-hydroxyethyl-
piperazine-N-2-ethanosulfonic acid)–Hanks buffer (HH; 10 mM
HEPES, pH 7.4), and 100 l of the solution was immobilized into
polystyrene microtiter plate wells (Maxisorp, Nunc, Denmark) by
overnight incubation at 4C by the method of Collado et al. (7).
Radiolabeled bacteria were harvested after overnight incubation
and washed twice with HH buffer. The A600 value was adjusted
to 0.25  0.05 to standardize the number of bacteria (approxi-
mately 108 CFU/ml), and 100 l of this suspension was added to
the wells and incubated for 1 h at 37C. Subsequently, the wells
were washed twice with 200 l of HH to remove unattached bac-
teria. Adhered bacteria were released and lysed with 1% (wt/vol)
sodium dodecyl sulfate (SDS) in NaOH (0.1 mol/liter, 200 l per
well) by incubation at 65C for 1 h. The contents of the wells
were transferred to microfuge tubes containing scintillation liquid
(OptiPhase ‘‘HiSafe 3,’’ Wallac, Turku, Finland), and radioactivity
was measured by liquid scintillation. Adhesion was expressed as
the percentage of radioactivity recovered after adhesion relative
to the radioactivity of the bacterial suspension added to the im-
mobilized mucus. Adhesion was determined in three independent
experiments, and each assay was performed in quadruplicate to
calculate intra-assay variation.
Inhibition of pathogen adhesion. To test the ability of the
LAB strains to inhibit the adhesion of pathogens, the procedure
described by Collado et al. (7) was used. In brief, unlabeled pro-
biotic bacteria (100 l, 108 CFU/ml) were added to the wells and
incubated for 1 h at 37C. Unbound LAB cells were removed by
washing twice with HH buffer, and radiolabeled pathogens (100
l, 108 CFU/ml) were added to the wells and incubated at 37C
for 1 h. Then, unbound labeled bacteria were washed, and the
bound bacteria were released and lysed with 1% (wt/vol) SDS in
0.1 M NaOH at 65C for 1 h. Radioactivity was assessed by liquid
scintillation. Results were expressed as the percentage of radio-
activity recovered after adhesion, relative to the radioactivity of
the bacterial suspension added to the wells. The percentage of
adhesion inhibition was calculated as the difference between the
adhesion of the pathogen in the absence and presence of lacto-
bacilli. Inhibition was determined in three independent experi-
ments, and each assay was performed in quadruplicate.
Displacement of pathogens. The ability of the probiotic
strains to displace previously adhered pathogens was assessed fol-
lowing the methodology described elsewhere (7). Radiolabeled
pathogens were added to the wells and incubated for 1 h at 37C;
after the removal of unbound pathogens by washing twice with
HH buffer, nonradiolabeled probiotics (100 l, 108 CFU/ml) were
added to the plates and incubated for 1 h at 37C. Then, the wells
were washed again, and the bound bacteria were released and
lysed as described above. Radioactivity was measured as previ-
ously described. Displacement of pathogens was calculated as the
difference between the adhesion of pathogens before and after the
addition of the LAB strains. At least three independent experi-
ments were carried out. Each assay was performed in quadrupli-
cate to calculate intra-assay variation.
Competition between pathogens and LAB strains. Com-
petitive exclusion of the pathogens by tested probiotics was de-
termined as described previously (25). Competitive exclusion was
calculated as the percentage of pathogens bound after the com-
bination with LAB relative to the pathogens bound in the absence
of LAB (control). At least three independent experiments were
carried out for each pathogenic strain.
For the competition test, a suspension of 50% probiotic and
50% radiolabeled pathogenic cells (108 CFU/ml) was added si-
multaneously to intestinal mucus (0.5 mg of protein per ml) and
incubated for 120 min at 37C. Also, we analyzed the influence
of the previous incubation in the competition test; for this, pro-
biotic and pathogen strains were mixed in the same proportions
and were incubated for 120 min at 37C. After incubation, the
mix was added to the intestinal mucus, and competitive adhesion
was assessed following the methodology described elsewhere (7).
After a total reaction time of 120 min for each condition, the cells
of the pathogen bound to the mucus were removed, and the ad-
hesion ratio (percent) was calculated as described above. For each
condition, wells with PBS only, instead of nonradiolabeled ad-
hesive cells, were included as controls, and the percentage of the
pathogenic cells bound was considered the reference value (0%).
Statistical analysis. Statistical analysis was done by SPSS
11.0 software (SPSS Inc., Chicago, Ill.). Data were subjected to
a one-way analysis of variance.
RESULTS
Adhesion of strains. The results of bacterial adhesion
to human intestinal mucus are shown in Figure 1. The ad-
hesion of LAB strains varied from 1.4 to 9.8%, depending
on the strain. The most adhesive L. plantarum strain was
IS-10506, with 9.8% adhesion, whereas the most adhesive
E. faecium strain was IS-16183, with 4.9% adhesion. With
regard to the pathogenic bacteria, C. histolyticum DSM 627,
E. coli K-2, and S. aureus DSM 20231 showed the highest
adhesion values (11.6 to 12.6%). The least adhesive path-
ogen was S. enterica serovar Typhimurium ATCC 12028,
which showed only 0.6% adhesion to human intestinal mu-
cus.
Inhibition of the adhesion of pathogens. Inhibition
of the adhesion of pathogenic microorganisms by the stud-
ied LAB strains depended on each strain and the pathogen
assayed (Table 1). All LAB strains isolated from dadih fer-
mented milk were able to significantly reduce (P  0.05)
the adhesion levels of all the pathogens tested. The reduc-
tion levels were highest for the five pathogens included in
this study. In general, L. plantarum strains showed better
inhibition abilities than E. faecium strains, but the differ-
ences were not significant (P  0.05). The data showed
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FIGURE 1. Adherence of probiotic strains (A) and pathogen
strains (B) to human intestinal mucus. Results were expressed as
average percent adhesion to mucus  standard deviation.
TABLE 1. Inhibition of pathogen adhesion by LAB strains isolated from dadih fermented milka
Strains
% adhesion inhibitionb
Bacteroides
vulgatus
Clostridium
histolyticum
Escherichia
coli
Salmonella
Typhimurium
Staphylococcus
aureus
E. faecium
E. faecium
E. faecium
L. plantarum
L. plantarum
IS-16183
IS-23427
IS-27526
IS-20506
IS-10506
37.2  11.9*c
24.5  0.7*
34.2  1.9*
44.0  11.5*
47.4  8.8*
29.5  6.5*
27.6  8.7*
25.5  5.3*
27.5  9.5*
29.7  9.4*
29.5  1.5*
35.5  0.9*
32.7  2.2*
34.7  10.5*
34.0  2.8*
27.2  5.3*
22.0  0.0*
37.6  14.6*
22.8  2.0*
24.5  6.3*
40.1  8.4*
29.5  7.8*
39.4  8.1*
38.9  6.8*
37.9  6.3*
a Results are expressed as average percent adhesion inhibition  standard deviation.
b Changes in the adhesion of pathogens in the absence of LAB (control) were assigned a value of 0%.
c Asterisks denote values significantly different from the control 0% (P  0.05).
that L. plantarum IS-10506 and E. faecium IS-27526 had
the highest inhibition abilities.
B. vulgatus was the pathogen that was easiest to be
inhibited by LAB strains isolated from dadih fermented
milk. The inhibition of L. plantarum strains ranged from
44.0 to 47.4%, whereas the inhibition of E. faecium strains
ranged from 24.5 to 37.2%. The best LAB strain to inhibit
B. vulgatus was E. faecium IS-16183, which significantly
decreased (P  0.05) pathogen adhesion by 37.2%.
C. histolyticum was the pathogen that was difficult to
be inhibited by LAB strains. Inhibition ranged from 25.5
to 29.7% for all LAB strains. The best LAB strain to inhibit
B. vulgatus was L. plantarum IS-10506, which significantly
decreased (P  0.05) pathogen adhesion by 29.7%.
All the other LAB strains were able to inhibit the ad-
hesion of at least one of the pathogenic strains tested. The
inhibition of S. aureus ranged from 29.5 to 40.1% for all
LAB strains, Salmonella inhibition ranged from 22.0 to
27.2%, and E. coli inhibition ranged from 29.5 to 35.5%.
Displacement of pathogens. The results of pathogen
displacement by LAB strains are shown in Table 2. All
pathogens were displaced by natural strains from dadih, al-
though differences were found among strains. Every LAB
strain was able to displace (P  0.05) all pathogens tested
in this study.
B. vulgatus was the pathogen that was easiest to be
displaced by LAB strains isolated from dadih fermented
milk (P  0.05), and the percentage of displacement ranged
from 60.7 to 66.2%. The best LAB strain to displace B.
vulgatus was E. faecium IS-16183 (66.2%). C. histolyticum
and S. aureus were the pathogens that were difficult to be
displaced by all LAB strains tested, and the displacements
ranged from 18.4 to 22.5% and 16.4 to 31.0% for C. his-
tolyticum and S. aureus, respectively. The best LAB strain
to inhibit C. histolyticum was E. faecium IS-16183, and for
S. aureus, it was L. plantarum IS-20506. All the other LAB
strains were able to inhibit the adhesion of at least three of
the pathogenic strains tested. The displacement of adhered
S. enterica serovar Typhimurium ranged from 53.3 to
61.5%, and the displacement of E. coli was from 59.9 to
64.6%.
Competition between pathogens and LAB strains.
Results of competitive exclusion studies between pathogens
and LAB strains with and without preincubation at 37C
for 2 h are presented in Table 3. The results show that
previous incubation at 37C for 2 h decreased the pathogen
adhesion to intestinal mucus, but this behavior depended on
each LAB strain and the pathogen assayed.
All tested LAB strains could compete and displace
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TABLE 2. Inhibition of pathogens by LAB strains isolated from dadih fermented milka
Strains
% displacement pathogenb
Bacteroides
vulgatus
Clostridium
histolyticum
Escherichia
coli
Salmonella
Typhimurium
Staphylococcus
aureus
E. faecium
E. faecium
E. faecium
L. plantarum
L. plantarum
IS-16183
IS-23427
IS-27526
IS-20506
IS-10506
66.2  4.9*c
65.7  5.4*
60.7  9.4*
61.6  9.8*
62.1  8.5*
22.5  1.9*
20.3  8.9*
19.3  2.9*
21.7  1.5*
18.4  4.2*
61.7  2.7*
59.9  2.7*
64.6  8.8*
63.8  1.5*
62.3  0.9*
61.5  3.1*
57.9  9.0*
53.3  3.3*
52.3  9.3*
57.3  15.3*
20.3  7.9*
18.3  8.8*
21.5  5.4*
31.0  6.2*
16.4  7.3*
a Results are expressed as average percent pathogen displaced  standard deviation.
b Changes in the adhesion of preadhered pathogens following the addition of buffer without LAB strains (control) were assigned a value
of 0%.
c Asterisks denote values significantly different from the control (P  0.05).
TABLE 3. Competence between pathogens and LAB strains isolated from dadih fermented milk to adhere to intestinal mucus with and
without preincubation for 2 h at 37Ca
Strains
Bacteroides
vulgatus
Clostridium
histolyticum
Escherichia
coli
Salmonella
Typhimurium
Staphylococcus
aureus
% pathogen inhibition without preincubationb
E. faecium
E. faecium
E. faecium
L. plantarum
L. plantarum
IS-16183
IS-23427
IS-27526
IS-20506
IS-10506
19.7  4.1*c
5.0  1.1*
28.4  8.7*
38.1  3.6*
	33.5  6.5*
	13.5  4.3*
	13.5  0.6*
	9.0  0.7*
4.9  1.8*
	9.9  7.0
43.0  3.8*
43.2  10.0*
41.3  1.1*
41.4  9.8*
39.5  7.2*
29.8  10.2*
32.9  17.0*
12.4  0.5*
18.0  4.3*
30.4  2.0*
28.5  6.5*
30.8  4.3*
36.3  11.1*
24.0  4.8*
27.3  4.6*
% pathogen inhibition with preincubationb
E. faecium
E. faecium
E. faecium
L. plantarum
L. plantarum
IS-16183
IS-23427
IS-27526
IS-20506
IS-10506
62.0  9.6*
66.8  9.2*
44.4  12.8*
46.2  12.2*
46.1  12.5*
28.5  6.1*
23.1  9.7*
14.4  9.5*
34.0  4.0*
32.8  5.0*
60.8  4.2*
62.5  3.2*
64.7  3.3*
63.5  6.3*
57.7  5.4*
42.1  11.1*
56.0  6.9*
32.8  6.0*
39.1  7.2*
37.5  3.3*
56.8  9.2*
59.4  4.3*
54.7  6.8*
58.2  8.6*
58.4  6.1*
a Results are expressed as average percent reduction  standard deviation.
b Changes in the adhesion of pathogens in the presence of dadith isolates. The control (pathogen adhesion) was assigned a value of 0%.
c Asterisks denote values significantly different from the control (P  0.05).
pathogens, although differences were found among strains.
Every LAB strain was able to compete and reduce (P 
0.05) the adhesion of E. coli K-2, S. enterica serovar Ty-
phimurium ATCC 12028, and S. aureus DSM 20231. The
values ranged from 39.5 to 43.2%, 12.3 to 32.9%, and 23.9
to 36.3%, respectively. In certain cases, the presence of
LAB increased the adhesion of B. vulgatus DSM 1447 and
C. histolyticum DSM 627. All strains, with one exception,
i.e., L. plantarum IS-20506, improved pathogen adhesion
from 9.0 to 13.5%. L. plantarum IS-10506 improved the
adhesion of B. vulgatus (33.5%).
Every LAB strain after incubation with pathogen
strains at 37C was able to compete and reduce (P  0.05)
the adhesion of E. coli K-2, S. enterica serovar Typhimu-
rium ATCC 12028, and S. aureus DSM 20231 by 57.7 to
64.7%, 32.8 to 56.0%, and 54.7 to 59.4%, respectively. Fur-
ther, all LAB strains reduced the adhesion of B. vulgatus
DSM 1447 and C. histolyticum DSM 627 from 44.4 to
66.8% and 14.5 to 34.00%, respectively.
DISCUSSION
Dadih is Indonesian traditional fermented buffalo milk
and is believed to be beneficial to human health (30, 31).
The natural, indigenous LAB observed in dadih could be
derived from bamboo tubes, buffalo milk, or banana leaves
involved in milk fermentation. Previous studies on the pro-
biotic properties of indigenous strains isolated from dadih
fermented milk have demonstrated that it exhibits antimu-
tagenic tolerance to gastrointestinal conditions (acid and
bile) as well as antipathogenic properties (8, 30, 31), and
all of these properties justified the selection of these LAB
strains. In the present study, we examined the adhesion of
these strains to human intestinal mucus and their abilities
against the in vitro colonization of selected pathogens (S.
aureus, S. enterica serovar Typhimurium, C. histolyticum,
E. coli, and B. vulgatus) to immobilized mucus extracted
from the human intestine. In this study, the adhesion of
these strains to human intestinal mucus and their ability to
inhibit adhesion, displace previously adhered pathogens,
and compete for adhesion sites in intestinal human mucus
were tested. Adhesion to intestinal mucosa has been re-
ported for most of the current probiotic strains with dem-
onstrated clinical efficacy. Adhesion may allow coloniza-
tion by the specific strain of the human gastrointestinal tract
(2). We used an immobilized human intestinal mucus model
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to simulate intestinal conditions. Good correlations have
been previously reported between this model and the en-
terocyte-like Caco-2 model (1, 21, 33).
The ability to exclude and displace pathogens from
mucus by specific probiotic strains has been reported in
other studies (7, 16). The difficulties involved in the anal-
ysis of bacterial adhesion in vivo have led to the develop-
ment of in vitro model systems for the selection of poten-
tially adherent strains. Many different intestinal mucosa
models have been used to assess the adhesive ability of
probiotics; among them, adhesion to human intestinal mu-
cus has been widely used (7, 14, 23, 25, 32). This study
has also used a reproducible and sensitive human intestinal
mucus model (33).
The adhesion levels obtained for LAB strains isolated
from dadih fermented milk ranged from 1.4 to 9.8%. Some
of the strains tested showed higher percentages of adhesion
than the commercial LAB strains used in other studies (12,
14). Interestingly, all the pathogens tested showed a high
adherence to intestinal mucus, with the exception of S. en-
terica serovar Typhimurium (adherence 
 0.6%). Patho-
gens have the capacity to bind to intestinal mucus, which
improves pathogen colonization in human intestinal mu-
cosa. Natural, indigenous probiotic microorganisms that
prevent and decrease pathogen adhesion are important and
relevant for the development of future probiotic foods from
natural strains. Five pathogens, i.e., S. enterica serovar Ty-
phimurium, E. coli, B. vulgatus, S. aureus, and C. histoly-
ticum, were selected, given their importance in human dis-
eases, to assess the ability of indigenous dadih strains to
inhibit the adhesion of pathogens, to displace adhered path-
ogens from mucus, and to compete with them in mucus
sites.
All tested LAB strains reduced pathogen adhesion (P
 0.05), and they could also displace preadhered pathogens
from intestinal mucus (P  0.05). However, great differ-
ences were observed, and adhesion was clearly demonstrat-
ed to be a strain-dependent property. Adhesion was also
dependent on the pathogen strain tested. Some of the LAB
strains showed high inhibition ability, with inhibition values
of over 40% for some of the pathogens tested. In accor-
dance with our results, it has been previously reported that
certain probiotic bacteria are able to inhibit the mucosal
adhesion of enteropathogenic E. coli and Salmonella by
competitive exclusion (3, 7).
The displacement of preadhered pathogens was also
found to be strain- and pathogen-dependent, and, as in the
inhibition of pathogen adhesion, no direct correlation was
found between the adhesion of LAB strains and the dis-
placement of pathogens. Interestingly, no association was
found between the results obtained for the adhesion inhi-
bition and the displacement of pathogens, indicating that
different mechanisms are involved in the processes. The
displacement of preadhering pathogens was also found to
be strain- and pathogen-dependent, and, as in the inhibition
of pathogen adhesion, no direct correlation was found be-
tween the adhesion of LAB strains and the displacement of
pathogens. Nevertheless, adhesion would appear to be one
of the factors involved. In this sense, the highly adhesive
L. plantarum IS-10506 was, in general, the most effective
strain against the pathogens tested. Interestingly, no relation
was found between adhesion inhibition and displacement
of pathogens, indicating that different mechanisms are in-
volved in these processes.
On the other hand, most LAB strains enhanced the ad-
hesion of pathogen strains during competition for mucus
sites; for example, the presence of most of the dadih iso-
lates improved C. histolyticum (P  0.05) adhesion to mu-
cus to between 9.0 and 13.5%. B. vulgatus adhesion in-
creased by 33.5% in the presence of L. plantarum IS-
10506. Although the biological importance of these increas-
es in pathogen adhesion is unknown, the enhanced adhesion
should be considered a risk factor associated with those
strains, and further evaluation of the competitive exclusion
properties should be conducted. Interestingly, when the
pathogen and probiotic mixture was incubated for 2 h at
37C prior to mucus adhesion, all LAB strains significantly
reduced pathogen adhesion. In most cases, the reduction of
pathogen adhesion was more than 50% greater than without
preincubation. In general, preincubation with LAB strains
reduced pathogen adhesion. This is consistent with the
coaggregation between pathogen and LAB strains shown in
previous studies (8). These results suggest that coaggrega-
tion mechanisms between pathogen and LAB strains are
involved in the reduction of pathogen adhesion to mucus.
Several reports show that the coaggregation abilities of
LAB strains may enable the formation of a barrier to pre-
vent colonization by pathogens (24, 27, 28). Also, adher-
ence of bacterial cells is usually related to cell surface char-
acteristics (4, 5). However, as reported earlier (4), no cor-
relation was found between adhesion and the pathogen in-
hibition ability of the LAB strains tested, indicating that, in
addition to the adhesion to mucus, other factors, such as
coaggregation with the pathogen, are involved.
Natural wild strains isolated from dadih typical Indo-
nesian fermented milk show inhibitory, competitive, and
displacing properties against pathogens, and they are prom-
ising candidates for future probiotics. However, considering
the high specificity of these processes, it is very important
to characterize the properties of the strains and strain com-
binations in order to select the best strain or strain combi-
nation for the prevention or treatment of specific infections.
For best results, selection of the right food matrix may also
be of importance. Taken together, our results suggest that
the procedures used are applicable to the selection and char-
acterization of new probiotic strains for human use, which
is relevant to future probiotic food development from nat-
ural strains. In this study, L. plantarum IS-10506 and E.
faecium IS-27526 appear to have the best properties of the
assessed isolates. As there are concerns about the use of
enterococci for human probiotic purposes, only the L. plan-
tarum strain remains a possible strain for further studies,
which should characterize the strain properties for food and
feed applications.
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